ArticleRadiological physics and technology2026
Enhancing proton therapy for superficial lesions using patient-specific bolus and multi-leaf collimator.
Article in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In scanning proton therapy for superficial tumors, offset range shifters (ORS) may degrade the lateral penumbra as the air gap increases. This study evaluated the dosimetric benefit of replacing ORS with 3D-printed patient-specific boluses (PSBs) and assessed the effectiveness of combining PSBs with multi-leaf collimators (MLCs). Head and breast phantoms were CT-scanned, and 4-cm-thick PSBs made of thermoplastic polyurethane (TPU) and silicone were fabricated. PSBs were modeled in the treatment planning system using measured water-equivalent thickness (WET). Virtual planning target volumes were defined in superficial layers. Treatment plans were generated with ORS or PSB, with and without MLC, at air gaps of 5–20 cm. Dose conformity was assessed using the conformity index at the 50% isodose level (CI50%) and penumbra width (distance from 80% to 20% dose). To validate dose calculations with PSBs, measured lateral dose distributions were compared with calculations using gamma analysis (3%/2 mm). With ORS, CI50% was 2.45 ± 0.08/2.57 ± 0.05 and penumbra was 15.6 ± 1.2 mm/15.1 ± 1.38 mm for head/breast cases, showing inferior conformity. PSBs achieved higher conformity regardless of air gap. When combined with MLCs, PSBs provided the best results (CI50% = 1.93 ± 0.03/2.04 ± 0.02; penumbra = 3.7 ± 0.4 mm/4.1 ± 0.1 mm). Gamma pass rates exceeded 95% in all cases, confirming agreement between measurement and calculation. PSBs improved dose conformity compared with ORSs in superficial proton therapy, and their combination with MLCs further enhanced treatment quality.
Indexed as
Identifiers
41706414What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.